Clinical Trials on Stargardt Disease 1 in United States

Total 146898 results

Alkeus Pharmaceuticals, Inc.

Enrolling by invitation

Open-Label Extension: Tolerability and Effects of ALK-001 on Stargardt Disease (TEASE)

Stargardt Disease | Stargardt Macular Degeneration | Stargardt Macular Dystrophy | Autosomal Recessive Stargardt Disease 1 (ABCA4-related)

United States
Alkeus Pharmaceuticals, Inc.

Recruiting

Phase 2 Tolerability and Effects of ALK-001 on Stargardt Disease (TEASE)

Stargardt Disease | Stargardt Macular Degeneration | Stargardt Macular Dystrophy | Autosomal Recessive Stargardt Disease 1 (ABCA4-related)

United States
Stargazer Pharmaceuticals, Inc.

Completed

Study of STG-001 in Subjects With Stargardt Disease

Stargardt Disease-1

United States
Sanofi

Active, not recruiting

Phase I/II Follow-up Study of SAR422459 in Patients With Stargardt's Macular Degeneration

Stargardt's Disease

United States, France
Sanofi

Terminated

Phase I/IIA Study of SAR422459 in Participants With Stargardt's Macular Degeneration

Stargardt's Disease

United States, France
National Eye Institute (NEI)

Completed

Effect of DHA Supplements on Macular Function in Patients With Stargardt Macular Dystrophy and Stargardt-like Macular Dystrophy

Macular Degeneration

United States
University of Utah

Completed

DHA Supplementation in Patients With STGD3

Dominantly Inherited Stargardt's Disease (STGD3)

United States
Belite Bio, Inc

Active, not recruiting

Study to Evaluate the Safety and Efficacy of Tinlarebant in the Treatment of Stargardt Disease in Adolescent Subjects Lesion(s) in Adolescent Subjects With STGD1 (DRAGON)

Stargardt Disease 1

United States, Australia, Belgium, China, France, Germany, Hong Kong, Netherlands, Switzerland, Taiwan, United Kingdom
IVERIC bio, Inc.

Active, not recruiting

Zimura Compared to Sham in Patients With Autosomal Recessive Stargardt Disease (STGD1)

Stargardt Disease 1

Italy, United States, Israel, United Kingdom, Germany, Spain, Hungary, France
Astellas Institute for Regenerative Medicine

Completed

Sub-retinal Transplantation of hESC Derived RPE(MA09-hRPE)Cells in Patients With Stargardt's Macular Dystrophy

Stargardt's Macular Dystrophy

United States
Astellas Institute for Regenerative Medicine

Completed

Long Term Follow Up of Sub-retinal Transplantation of hESC Derived RPE Cells in Stargardt Macular Dystrophy Patients

Stargardt's Macular Dystrophy

United States
National Eye Institute (NEI)

Recruiting

Rod and Cone Mediated Function in Retinal Disease

Retinal Degeneration | Retinitis Pigmentosa | Stargardt's Disease

United States
Retina Institute of Hawaii

Completed

Microcurrent Stimulation to Treat Macular Degeneration

Retinal Diseases | Retinitis Pigmentosa | Stargardt's Disease

United States
Astellas Institute for Regenerative Medicine

Completed

A Follow up Study to Determine the Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial (hESC-RPE) Cells in Patients With Stargardt's Macular Dystrophy (SMD)

Stargardt's Macular Dystrophy

United Kingdom
Astellas Institute for Regenerative Medicine

Completed

Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial (hESC-RPE) Cells in Patients With Stargardt's Macular Dystrophy (SMD)

Stargardt's Macular Dystrophy

United Kingdom
University of Utah

Completed

Phase 1 Pilot Study of 4-MP to Treat Stargardt Macular Dystrophy

Macular Dystrophy, Corneal

United States
Queen's University, Belfast
University of Sussex

Unknown

Visual Performance Measures in a Virtual Reality Environment for Assessing Clinical Trial Outcomes in Those With Severely Reduced Vision

Retinitis Pigmentosa | Low Vision | Albinism | Stargardt Disease 1 | Stargardt Disease 3 | Stargardt Disease 4

United Kingdom
National Eye Institute (NEI)
National Cancer Institute (NCI)

Recruiting

Stargardt-like Macular Dystrophy (STDG3) Secondary to Mutations in ELOVL4

Stargardt-Like Macular Dystrophy

United States
Nanoscope Therapeutics Inc.

Completed

Safety and Effects of a Single Intravitreal Injection of vMCO-010 Optogenetic Therapy in Subjects With Stargardt Disease (STARLIGHT)

Stargardt Disease

United States
Nanoscope Therapeutics Inc.

Enrolling by invitation

Non-interventional Long Term Follow-up Study of Participants Previously Enrolled in the STARLIGHT Study (SUSTAIN)

Stargardt Disease

United States
University of Michigan
Midwest Eye Banks

Terminated

Novel Quantification Methods for Fluorescence to Detect Progression in Stargardt Disease

Stargardt Disease

United States
National Eye Institute (NEI)

Active, not recruiting

Natural History of Eye Diseases Related to ABCA4 Mutations

Retinal Degeneration | ABCA4-Related Retinopathies

United States
Ocugen

Recruiting

Study to Assess the Safety and Efficacy of OCU410ST for Stargardt Disease (GARDian)

Stargardt Disease

United States
National Eye Institute (NEI)

Recruiting

Oral Metformin for Treatment of ABCA4 Retinopathy

Retinal Degeneration | Stargardt Disease | ABCA4 Retinopathy | Retinal Dystrophy

United States
Foundation Fighting Blindness
United States Department of Defense

Completed

A Natural History of the Progression of Stargardt Disease: Retrospective and Prospective Studies (ProgSTAR)

Stargardt Disease

United States, United Kingdom, France, Germany
Johns Hopkins University
The Shulsky Foundation

Completed

The Natural History of the Progression of Atrophy Secondary to Stargardt Disease Type 4: PROM1-Related Macular Dystrophy (ProgStar-4)

Stargardt Disease

Germany, United States, United Kingdom
Kubota Vision Inc.

Completed

Pharmacodynamic Study of Emixustat Hydrochloride in Subjects With Macular Atrophy Secondary to Stargardt Disease

Stargardt Disease | Macular Atrophy

United States
Eledon Pharmaceuticals

Withdrawn

Safety, Tolerability, and Efficacy of Immunomodulation With AT-1501 in Combination With Transplanted Islet Cells in Adults With Brittle T1D

Brittle Type 1 Diabetes Mellitus

United States
Graviton Bioscience Corporation

Completed

Safety, Tolerability, and Pharmacokinetic Study of Single Ascending Dose of GV101 in Healthy Subjects

Phase 1

United States
Eddii, Inc.

Completed

Safety and Feasibility Study of the Eddii Mobile Application

Type-1 Diabetes

United States
NYU Langone Health
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Cholesterol Lowering and Residual Risk in Diabetes, Type 1 (CHORD1)

Type 1 Diabetes

United States
Boston Children's Hospital

Completed

Group Education Curriculum for Older Teens With Type 1 Diabetes (SMART T1D)

Type 1 Diabetes Mellitus

United States
Vanderbilt University Medical Center

Completed

Check It! Positive Psychology Intervention to Improve Adherence in Adolescents With T1D

Type 1 Diabetes Mellitus

United States
Joslin Diabetes Center
Novo Nordisk A/S

Terminated

Glycemic Stability of Insulin Aspart Versus Insulin Lispro in Insulin Pump Therapy

Type 1 Diabetes Mellitus

United States
Legacy Health System
Juvenile Diabetes Research Foundation

Completed

Artificial Pancreas Control System in an Outpatient Setting

Type 1 Diabetes Mellitus

United States
Kubota Vision Inc.
Food and Drug Administration (FDA)

Completed

Safety and Efficacy of Emixustat in Stargardt Disease (SeaSTAR)

Stargardt Disease

United States, United Kingdom, Germany, Spain, Brazil, Canada, Denmark, France, Italy, Netherlands, South Africa
Vanderbilt University Medical Center
University of Connecticut

Completed

Communication and Coping for Mothers of Adolescents With Type 1 Diabetes (T1D)

Type 1 Diabetes Mellitus

United States
Massachusetts General Hospital
Boston University

Terminated

Individualizing Automated Closed Loop Glucose Control Through Pharmacokinetic Profiling in an Insulin-Only Bionic Pancreas

Type 1 Diabetes Mellitus

United States
University of Florida
Juvenile Diabetes Research Foundation; National Institutes of Health (NIH)

Completed

Umbilical Cord Blood Infusion to Treat Type 1 Diabetes

Type 1 Diabetes Mellitus

United States
Jaeb Center for Health Research
The Leona M. and Harry B. Helmsley Charitable Trust; Indiana University School...

Completed

Strategies to Enhance New CGM Use in Early Childhood (SENCE) (SENCE)

Type 1 Diabetes Mellitus

United States
Oregon Health and Science University

Completed

Single Hormone Closed Loop Study With PDT Sensor

Type 1 Diabetes Mellitus

United States
Boston Children's Hospital

Completed

Closed-Loop Insulin Delivery in Children Less Than 7 Years of Age

Type 1 Diabetes Mellitus

United States
Boston Children's Hospital

Completed

Telehealth Intervention for Youth With T1DM

Type 1 Diabetes Mellitus

United States
Legacy Health System
Juvenile Diabetes Research Foundation

Completed

Continuous Glucose Monitoring to Measure Effect of Glycemic Index

Type 1 Diabetes Mellitus

United States
University of Colorado, Denver
The Leona M. and Harry B. Helmsley Charitable Trust; Nova Immunotherapeutics...

Recruiting

MER3101: MAS-1 Adjuvanted Antigen-specific Immunotherapeutic for Prevention and Treatment of Type 1 Diabetes (MER3101)

Type 1 Diabetes Mellitus

United States
University of Illinois at Chicago
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Loyola...

Completed

A Cognitive Behavioral Therapy (CBT) Intervention to Reduce Fear of Hypoglycemia in Type 1 Diabetes (CBT)

Type 1 Diabetes Mellitus

United States
National Institute of Diabetes and Digestive and...

Completed

Solitary Islet Transplantation for Type 1 Diabetes Mellitus Using Steroid Sparing Immunosuppression

Diabetes Mellitus Type 1

United States
University of Texas Southwestern Medical Center
University of Massachusetts, Worcester

Completed

Pet Ownership and Glucose Control in Type 1 Diabetes

Type 1 Diabetes Mellitus

United States
Sue Brown
DexCom, Inc.; Roche Diagnostics

Terminated

Early Feasibility Study of Adaptive Advisory/Automated (AAA) Control of Type 1 Diabetes

Type 1 Diabetes Mellitus

United States
University of Virginia
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); DexCom... and other collaborators

Completed

Feasibility Study of Closed Loop Control in Type 1 Diabetes Using Heart Rate Monitoring as an Exercise Marker

Type 1 Diabetes Mellitus

United States

Clinical Trials on Stargardt Disease 1 in United States

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Australia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations